MannKind and Rose Pharma Enter Global Collaboration to Develop Inhaled GLP-1 for Weight Management
MannKind and Rose Pharma have entered a worldwide collaboration to develop ROSE-010 Technosphere, an investigational rapid-acting inhaled GLP-1 therapy for weight management.
Rose Pharma | 10/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy